Laura Pavan

Vicenza, 36100, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

Gene Expression, Non-Coding RNA, and Circular RNA Alterations in Patients with T-Prolymphocytic Leukemia.

Journal: Cancers

Published: June 24, 2026

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort.

From variant detection to interpretation in idiopathic erythrocytosis: A structured approach applied to a clinical cohort.

Journal: British journal of haematology

Published: March 24, 2026

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real-World International Experience.

Journal: American journal of hematology

Published: January 30, 2026

A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone.

A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone.

Journal: Haematologica

Published: November 17, 2025

Belamaf: is renal toxicity an overlooked side effect?

Belamaf: is renal toxicity an overlooked side effect?

Journal: Blood advances

Published: September 09, 2025

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Refining the role of selinexor in multiple myeloma: strategic use in a shifting treatment landscape.

Journal: ESMO open

Published: July 11, 2025

Prognostic stratification of standard risk multiple myeloma defined by revised international scoring system.

Prognostic stratification of standard risk multiple myeloma defined by revised international scoring system.

Journal: Leukemia & lymphoma

Published: May 20, 2025

An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma.

An Update of the Appropriate Sequencing for Salvage Therapies in Multiple Myeloma.

Journal: Mediterranean journal of hematology and infectious diseases

Published: March 17, 2025

A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.

Journal: Cancer medicine

Published: September 19, 2023

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.

Journal: Annals of hematology

Published: August 04, 2023

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.

Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies.

Journal: Frontiers in oncology

Published: April 26, 2023

Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.

Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital.

Journal: HemaSphere

Published: April 21, 2023

Showing 1-12 of 22

Last Updated: 09/26/2026